(-0.91%) 5 003.25 points
(-0.77%) 37 715 points
(-1.05%) 17 363 points
(2.10%) $84.47
(0.85%) $1.772
(-0.02%) $2 397.60
(-0.39%) $28.27
(-0.68%) $948.00
(0.12%) $0.940
(0.19%) $11.06
(0.15%) $0.805
(-0.23%) $93.69
@ $3.89
Issued: 13 Feb 2024 @ 15:43
Return: -4.76%
Previous signal: Feb 13 - 09:30
Previous signal:
Return: -4.07 %
Live Chart Being Loaded With Signals
Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections...
Stats | |
---|---|
Today's Volume | 267 759 |
Average Volume | 421 064 |
Market Cap | 311.41M |
EPS | $0 ( 2024-02-28 ) |
Next earnings date | ( $-0.610 ) 2024-05-13 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -2.27 |
ATR14 | $0.00200 (0.05%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-01-31 | Corcoran Andrea | Buy | 44 367 | Common Stock |
2024-02-01 | Corcoran Andrea | Sell | 15 843 | Common Stock |
2024-01-31 | Corcoran Andrea | Buy | 200 000 | Stock Option (Right to Buy) |
2024-01-31 | Corcoran Andrea | Sell | 44 367 | Restricted Stock Units |
2024-01-31 | Sommadossi Jean-pierre | Buy | 448 000 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
72.92 |
Last 99 transactions |
Buy: 22 764 762 | Sell: 12 804 280 |
Volume Correlation
Atea Pharmaceuticals, Correlation
10 Most Positive Correlations | |
---|---|
TRIT | 0.954 |
NAKD | 0.953 |
SIRI | 0.941 |
IMV | 0.938 |
TNGX | 0.938 |
JRJC | 0.935 |
IMPL | 0.935 |
APM | 0.934 |
UK | 0.933 |
GSMG | 0.932 |
10 Most Negative Correlations | |
---|---|
KIN | -0.962 |
IDCC | -0.958 |
COUP | -0.949 |
TA | -0.946 |
PAE | -0.945 |
PDFS | -0.944 |
SLMBP | -0.944 |
INOD | -0.943 |
PEGA | -0.943 |
NCAC | -0.942 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Atea Pharmaceuticals, Correlation - Currency/Commodity
Atea Pharmaceuticals, Financials
Annual | 2023 |
Revenue: | $0 |
Gross Profit: | $-416 000 (0.00 %) |
EPS: | $-1.630 |
Q4 | 2023 |
Revenue: | $0 |
Gross Profit: | $-104 000 (0.00 %) |
EPS: | $-0.470 |
Q3 | 2023 |
Revenue: | $0 |
Gross Profit: | $-104 000 (0.00 %) |
EPS: | $-0.400 |
Q2 | 2023 |
Revenue: | $0 |
Gross Profit: | $-104 000 (0.00 %) |
EPS: | $-0.340 |
Financial Reports:
No articles found.
Atea Pharmaceuticals,
Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The company also develops AT-752, an oral purine nucleoside prodrug product candidate, which has completed Phase Ia clinical trial for the treatment of dengue; AT-777, an NS5A inhibitor; AT-787, a co-formulated, oral, pan-genotypic fixed dose combination of AT-527 and AT-777 for the treatment of hepatitis C virous (HCV); and AT-281, a pharmaceutically acceptable salt for the treatment or prevention of an RNA viral infection, including dengue fever, yellow fever, Zika virus, and coronaviridae viral infection, as well as Ruzasvir, an investigational oral, pan genotypic NS5A inhibitor for the treatment of chronic HCV infection. It has a license agreement with Merck & Co, Inc. for development and commercialization of ruzasvir for the treatment of HCV. Atea Pharmaceuticals, Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators